K
Kyle Rudser
Researcher at University of Minnesota
Publications - 200
Citations - 4652
Kyle Rudser is an academic researcher from University of Minnesota. The author has contributed to research in topics: Mucopolysaccharidosis type I & Transplantation. The author has an hindex of 31, co-authored 176 publications receiving 3792 citations. Previous affiliations of Kyle Rudser include University of Calgary & University of Washington.
Papers
More filters
Journal ArticleDOI
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Bryan Kestenbaum,Joshua N. Sampson,Kyle Rudser,Donald J. Patterson,Stephen L. Seliger,Bessie A. Young,Bessie A. Young,Donald J. Sherrard,Dennis L. Andress +8 more
TL;DR: Elevated serum phosphate levels were independently associated with increased mortality risk among this population of patients with chronic kidney disease and were associated with a significantly increased risk for death.
Journal ArticleDOI
Fracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients
TL;DR: Fracture risks were lower among hemodialysis patients who underwent PTX compared with matched control subjects, suggesting that surgical amelioration of secondary hyperparathyroidism may outweigh the risk of parathyroid hormone oversuppression in terms of bone health.
Journal ArticleDOI
The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity: A Randomized, Placebo-Controlled, Clinical Trial
Aaron S. Kelly,Kyle Rudser,Brandon M. Nathan,Claudia K. Fox,Andrea M. Metzig,Brandon J. Coombes,Angela K. Fitch,Eric M. Bomberg,M. Jennifer Abuzzahab +8 more
TL;DR: Preliminary evidence supporting the feasibility, safety, and efficacy of GLP-1 receptor agonist therapy for the treatment of severe obesity in adolescents is provided.
Journal ArticleDOI
Differences in kidney function and incident hypertension: The multi-ethnic study of atherosclerosis
Bryan Kestenbaum,Kyle Rudser,Ian H. de Boer,Carmen A. Peralta,Linda F. Fried,Michael G. Shlipak,Walter Palmas,Catherine Stehman-Breen,David S. Siscovick +8 more
TL;DR: S serum cystatin C levels and the urinary albumincreatinine ratio were evaluated separately and in combination as predictors of incident hypertension in a multiethnic, community-based cohort without clinically recognized kidney or cardiovascular disease.
Journal ArticleDOI
Exenatide as a Weight-Loss Therapy in Extreme Pediatric Obesity A Randomized, Controlled Pilot Study
Aaron S. Kelly,Andrea M. Metzig,Kyle Rudser,Angela K. Fitch,Claudia K. Fox,Brandon M. Nathan,Mary M. Deering,Betsy L. Schwartz,M. Jennifer Abuzzahab,Laura M. Gandrud,Antoinette Moran,Charles J. Billington,Charles J. Billington,Sarah Jane Schwarzenberg +13 more
TL;DR: Preliminary data suggest that exenatide should be evaluated in larger, well‐controlled trials for its ability to reduce BMI and improve cardiometabolic risk factors in youth with extreme obesity.